Skip to content

New Feature Updates

New Feature Updates

It’s a new feature alert! At Arfinn Med we always work to make sure we are the industry leading software platform and EMR for medical cannabis providers and clinics. Keeping with that sentiment, we’ve recently updated two features that have been very popular with Arfinn Med users.  Those are the customizable consent and confirmation page features that can be enabled. Read below to see how you can use these features to make sure all patients are ready to go prior to your appointments and key information is reinforced, reducing time costly omissions.

Customize Your Consents

If you wish to create your own consents and make them part of your intake forms, we now have an easier process to do so. 

When logged in, hover over your settings and select the ‘Patient Portal’ setting.

Once there, turn the ‘Custom Consent’ to ‘Yes’ and a label and text box will appear.  Here you can enter the text that you require patients to sign. 

If you have more than one consent that you require, select the + button to the right of the text box to generate a new label and box.  When you are done, hit the ‘Update’ button.  The consent(s) will now be live on your intake forms and will be time-stamped, signed, and stored with the medical record.

Customize Your Intake Confirmation Page

If you want to remind patients of what to bring to an appointment, direct them to state registries, or simply just list your location again, we now have an easy way to do so with our ‘Directory Profile’ setting.

Once logged in, hover over Settings and select ‘Directory Profile’. 

Scroll down to the text box labeled ‘Thank You Page Text’ and type or paste your customized message.  The box accepts html so you can customize its content and appearance even more. Once you are done, select ‘Update’ and your new ‘Confirmation/Thank You’ page will be displayed after a patient completes the intake form.

Stories you may be interested in

Cannabis for Treating IBD: Hope or Hype?

Nausea, abdominal pain and changes in appetite. These are all things that can significantly impact one’s wellbeing if left untreated, yet they have all shown marked improvements when associated with cannabis. Yet, less is known about the effects of cannabis on inflammatory bowel disease, or IBD, a chronic inflammatory condition that impacts the gastrointestinal tract…
Read More

LEGALIZING CANNABIS LINKED TO LESS OPIOID PRESCRIPTIONS, COULD HELP COMBAT EPIDEMIC, SCIENTISTS SAY

There are less opioid prescriptions on average in U.S. states where medical and recreational marijuana are legal, research has revealed. Access to recreational cannabis in the U.S. was tied with a 11.8 percent lower rate of opioids prescriptions each day, and 4.2 percent for medical marijuana. The authors of the paper published in the Journal of Health Economics said recreational weed…
Read More

Medical Cannabis and Breast Cancer

October is breast cancer awareness month and we at Arfinn Med would like to reiterate the importance of early screening and regular tests.  According to the American Cancer Society: “Breast cancer is the most common cancer in American women, except for skin cancers. Currently, the average risk of a woman in the United States developing breast…
Read More

Customize Your Patient Notes with Arfinn Med

Joining the text messaging update, the Arfinn Med portal now presents the ability to create note taking templates. This innovative addition will allow physicians to streamline the data and information that they are collecting from patients, resulting in their cases staying aligned and concise. Additionally, through this function, physicians will be able to pick and…
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More

Colorado looks to medical marijuana to ease opioid crisis

As the nation grapples with an opioid crisis that kills more than 130 people every day, Colorado thinks a solution may lie in a joint, a vape pen or a topical. On Friday, it becomes the third state in the nation after New York and Illinois to allow doctors to recommend medical marijuana for any condition…
Read More

Leave a Comment

You must be logged in to post a comment.